Clinical Trial Update: Masitinib in Combination With FOLFIRI in Third or Fourth Line of Treatment of Patients With Metastatic Colorectal Cancer [Phase 2, Phase 3]

View source ↗

Summary

Clinical trial update for masitinib combined with FOLFIRI in advanced metastatic colorectal cancer (third or fourth line) across Phase 2 and Phase 3, status com…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• FOLFIRI (irinotecan, leucovorin, 5-fluorouracil)
• Masitinib (masitinib)

Snippet

Sponsor: AB Science | Conditions: Colorectal Cancer Metastatic | Phase 2, Phase 3 | Status: COMPLETED